Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency

被引:54
|
作者
Speiser, PW
机构
[1] N Shore Long Isl Jewish Hlth Syst, Div Pediat Endocrinol, Manhasset, NY 11030 USA
[2] NYU, Sch Med, Dept Clin Pediat, Manhasset, NY USA
关键词
D O I
10.1016/S0889-8529(08)70018-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congenital adrenal hyperplasia (CAH) owing to 21-hydroxylase deficiency is the most common cause of genital ambiguity in the newborn and is present in about 1 in 15,000 live births worldwide. The disease is further characterized in its classic salt-wasting form (similar to 75% of cases) by potentially Lethal adrenal insufficiency. A nonsalt-wasting form of classic CAH with 21-hydroxylase deficiency is also recognized by genital ambiguity in affected females and by signs of androgen excess in later childhood in males. Nonclassic CAH with 21-hydroxylase deficiency may be detected in 1% to 3% of populations and is often mistaken for idiopathic precocious pubarche in children or polycystic ovary syndrome m young women. This article presents an overview of clinical and genetic aspects of the various forms of CAH with 21-hydroxylase deficiency.
引用
收藏
页码:31 / +
页数:30
相关论文
共 50 条
  • [1] Prenatal diagnosis of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
    Yau, Mabel
    Pina, Christian
    Khattab, Ahmed
    Barhen, Ariella
    New, Maria I.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (05): : 487 - 490
  • [2] Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency presenting with erythrocytosis
    Ramos, Ignacio
    Regadera, Anabel
    Roman, Pilar
    Ezquieta, Begona
    [J]. MEDICINA CLINICA, 2008, 131 (16): : 638 - 639
  • [3] Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
    Nimkarn, Saroj
    New, Maria I.
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (05): : 405 - 413
  • [4] Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
    Saroj Nimkarn
    Maria I New
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 405 - 413
  • [5] 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
    Shaw, Amy M.
    [J]. NEONATAL NETWORK, 2010, 29 (03): : 191 - 196
  • [6] Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency - Growth, development, and therapeutic considerations
    Migeon, CJ
    Wisniewski, AB
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2001, 30 (01) : 193 - +
  • [7] Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    White, PC
    Speiser, PW
    [J]. ENDOCRINE REVIEWS, 2000, 21 (03) : 245 - 291
  • [8] 21-HYDROXYLASE DEFICIENCY CONGENITAL ADRENAL-HYPERPLASIA
    NEW, MI
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 48 (01): : 15 - 22
  • [9] Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia
    Parsa, Alan A.
    New, Maria I.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 165 : 2 - 11
  • [10] Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
    Merke, Deborah P.
    Auchus, Richard J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (13): : 1248 - 1261